Article Dans Une Revue Disease Models & Mechanisms Année : 2023

Probing the Pathogenicity of Patient-Derived Variants of MT-ATP6 in Yeast

Résumé

ABSTRACT The list of mitochondrial DNA (mtDNA) variants detected in individuals with neurodegenerative diseases is constantly growing. Evaluating their functional consequences and pathogenicity is not easy, especially when they are found in only a limited number of patients together with wild-type mtDNA (heteroplasmy). Owing to its amenability to mitochondrial genetic transformation and incapacity to stably maintain heteroplasmy, and the strong evolutionary conservation of the proteins encoded in mitochondria, Saccharomyces cerevisiae provides a convenient model to investigate the functional consequences of human mtDNA variants. We herein report the construction and energy-transducing properties of yeast models of eight MT-ATP6 gene variants identified in patients with various disorders: m.8843T>C, m.8950G>A, m.9016A>G, m.9025G>A, m.9029A>G, m.9058A>G, m.9139G>A and m.9160T>C. Significant defect in growth dependent on respiration and deficits in ATP production were observed in yeast models of m.8950G>A, m.9025G>A and m.9029A>G, providing evidence of pathogenicity for these variants. Yeast models of the five other variants showed very mild, if any, effect on mitochondrial function, suggesting that the variants do not have, at least alone, the potential to compromise human health.
Fichier principal
Vignette du fichier
dmm049783.pdf (5.97 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04833192 , version 1 (12-12-2024)

Licence

Identifiants

Citer

Emilia Baranowska, Katarzyna Niedzwiecka, Chiranjit Panja, Camille Charles, Alain Dautant, et al.. Probing the Pathogenicity of Patient-Derived Variants of MT-ATP6 in Yeast. Disease Models & Mechanisms, 2023, 16 (4), pp.dmm049783. ⟨10.1242/dmm.049783⟩. ⟨hal-04833192⟩

Collections

CNRS
9 Consultations
1 Téléchargements

Altmetric

Partager

More